Wani sabon bincike ya nuna cewa Champix (Pfizer), wannan shahararren maganin daina shan taba ba zai iya saba wa abin da aka fada a baya ba. ƙara haɗarin damuwa da bugun zuciya.
Binciken, wanda aka buga a The Lancet (sake su) ya bi fiye da haka 160 000 marasa lafiya wanda ya karbi maganin maye gurbin nicotine na tsawon shekaru biyar tare da maganin shan taba GlaxoSmithKline Zyban (bupropion) ko Champix daga Pfizer (varenicline).
Masu bincike sun gano cewa mutane suna shan champix ko Zyban ba su da yuwuwar kamuwa da ciwon zuciya ko haɓaka alamun damuwa fiye da waɗanda ke amfani da wasu hanyoyin daban. Bugu da ƙari, yin amfani da Champix yana da alaƙa da raguwar haɗarin cututtukan zuciya na ischemic, raunin kwakwalwa, raunin zuciya, arrhythmia da damuwa.
Sheikh Aziz, daya daga cikin masu bincike na binciken kuma babban darektan Cibiyar Nazarin Lafiya ta Jami'ar Edinburgh, ya ce: Bisa ga zurfin bincikenmu, mun yi imanin cewa abu ne mai wuya hakan
varenicline yana da mummunar illa ga zuciya ko lafiyar kwakwalwa.". " Masu gudanarwa irin su Hukumar Abinci da Magunguna (FDA) yakamata su sake duba gargaɗin lafiyarsu game da Champix don kada a iyakance damar yin amfani da wannan ingantaccen taimakon daina shan taba.. "
Sakamakon ya zo a matsayin labari mai daɗi ga Pfizer, wanda ya riga ya gudanar da irin wannan binciken don tantance lafiyar neuropsychiatric na samfuran su, wanda sakamakonsa zai kasance nan gaba a wannan shekara. Champix, wanda aka sayar da shi a matsayin Chantix a Amurka, ya sami tallace-tallace na dala miliyan 647 a duniya a cikin 2014, wanda ya sa ya zama daya daga cikin manyan sayar da magungunan daina shan taba. Duk da haka, an ba cece-kucen da ke tattare da illolinsa, tallace-tallace ya ragu daga shekarar 2007.
Bayani game da marubutan binciken : Malamin. Daniel Kotz ya sami kyauta mara izini daga Pfizer don gwajin dakatar da shan taba a waje da aikin da aka gabatar kuma yana tallafawa ta hanyar tallafi daga Ma'aikatar Innovation, Kimiyya da Bincike na Tarayyar Jamus ta Rhineland na Arewa-Westphalia.
Malamin. Robert West ya karbi tallafi, kudade na sirri, da tallafin kuɗi daga Pfizer, GlaxoSmithKline, da Johnson & Johnson, da kuma kudade na sirri daga Novartis, a waje da aikin da aka gabatar. Malamin. Sunan mahaifi CP van Schaycka ya sami tallafin bincike daga Pfizer a wajen aikin da aka nuna. Masu kera varenicline da bupropion ba su da hannu a kowane mataki na wannan aikin. Malamin. Sheikh Aziz a halin da ake ciki yana tallafawa Cibiyar Farr, wanda ke samun goyon bayan ƙungiyar masu ba da kuɗi a ƙarƙashin jagorancin Majalisar Binciken Likita da Asusun Commonwealth; Ra'ayoyin da aka gabatar anan sune na SA kuma ba lallai ba ne na Asusun Commonwealth, daraktocin sa, jami'anta, ko ma'aikata. Babu wani rikici na sha'awa ga sauran marubutan binciken.
Tun daga 2008, miyagun ƙwayoyi ya kasance a tsakiyar kusan shari'o'i 3000, duk da haka, Pfizer ya warware dukkan lamuran a watan Yuni 2013.
source : pmlive.com
